AdvaMed Seeks More Safeguards For Distributing Off-Label Journal Articles

The device industry wants more protection than that supplied in draft FDA guidance on appropriate dissemination of journal articles for studies of non-approved product uses, while some members of Congress believe distribution of off-label study information should be banned outright